2024

1. Biomarkers Promising Tools Towards the Diagnosis, Prognosis, and Treatment of Myopia

Varis Ruamviboonsuk, Carla Lanca and Andrzej Grzybowski

2. Corneal Biomechanical Characteristics in Myopes and Emmetropes Measured by Corvis ST 2024

MIN-XIN LIU, KE-YAO ZHU, DAN-LIN LI, XING-XUAN DONG, GANG LIANG, ANDRZEJ GRZYBOWSKI AND CHEN-WEI PAN

3. Corrigendum Effectiveness of myopia control interventions a systematic review of 12 randomized control trials published between 2019 and 2021

Carla Lanca, Chi Pui Pang, Andrzej Grzybowski

4. DNA methylation biomarkers and myopia a multi-omics study integrating GWAS, mQTL and eQTL data

Xing-Xuan Dong, Dong-Ling Chen, Hui-Min Chen, Dan-Lin Li, Dan-Ning Hu, Carla Lanca, Andrzej Grzybowski and Chen-Wei Pan

5. Efficacy and Safety of 0.03% Atropine Eye Drops in Controlling Myopia Progression A One-Year Prospective Clinical Study

Dovile Simonaviciute, Andrzej Grzybowski , Arvydas Gelzinis and Reda Zemaitiene

6. Lower indoor spatial frequency increases the risk of myopia in children

Dan-Lin Li, Xing-Xuan Dong, Jin-Liu-Xing Yang, Carla Lanca, Andrzej Grzybowski, Chen-Wei Pan

7. Myopia Control in Caucasian Children with 0.01% Atropine Eye Drops 1-Year Follow-Up Study

Dovile Simonaviciute, Arvydas Gelzinis, Laura Kapitanovaite, Andrzej Grzybowski and Reda Zemaitiene

8. Myopia Control – Are We Ready for an Evidence Based Approach

Leila Sara Eppenberger, Andrzej Grzybowski, Leopold Schmetterer, Marcus Ang

9. Myths in Myopia Epidemiology and Treatment

Carla Lanca, Michael X. Repka, Andrzej Grzybowski

10. Predicting Children’s Myopia Risk A Monte Carlo Approach to Compare the Performance of Machine Learning Models

Piotr Artiemjew1, Radosław Cybulski1, Mohammad Hassan Emamian, Andrzej Grzybowski3, Andrzej Jankowski, Carla Lanca, Shiva Mehravaran5, Marcin Młynski, Cezary Morawski, Klaus Nordhausen, Olavi Parssinen and Krzysztof Ropiak

11. Will the new anti-myopia spectacles be the standard of care in future AJO 2024

Carla Lanca PhD, Chen-Wei Pan MD, PhD, Andrzej Grzybowski MD, PhD, MBA, MAE, FEVER

2024

Fundacja Wspierania Rozwoju Okulistyki “Okulistyka21”